These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26448312)

  • 1. Cosmetic Effects of Ingenol Mebutate Gel in the Treatment of Field-Cancerized Photodamaged Skin.
    Braun SA; Gerber PA
    Dermatol Surg; 2015 Nov; 41(11):1328-9. PubMed ID: 26448312
    [No Abstract]   [Full Text] [Related]  

  • 2. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring Ingenol Mebutate Gel Treatment of Actinic Keratoses by Reflectance Confocal Microscopy.
    López Estebaranz JL; Pampín Franco A; Gamo Villegas R; Floristán U
    Acta Derm Venereol; 2017 May; 97(5):646-648. PubMed ID: 28093603
    [No Abstract]   [Full Text] [Related]  

  • 4. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.
    Siller G; Gebauer K; Welburn P; Katsamas J; Ogbourne SM
    Australas J Dermatol; 2009 Feb; 50(1):16-22. PubMed ID: 19178487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives.
    Gameiro L; Tovo LFR; Sanches Júnior JA; Aprahamian I
    An Bras Dermatol; 2019 Jul; 94(3):313-319. PubMed ID: 31365660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm
    Hanke CW; Albrecht L; Skov T; Larsson T; Østerdal ML; Spelman L
    J Am Acad Dermatol; 2020 Mar; 82(3):642-650. PubMed ID: 31374304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP).
    Tzogani K; Nagercoil N; Hemmings RJ; Samir B; Gardette J; Demolis P; Salmonson T; Pignatti F
    Eur J Dermatol; 2014; 24(4):457-63. PubMed ID: 25115145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Response to Ingenol Mebutate in Patients With Actinic Keratoses.
    Batalla A; Flórez Á; Feal C; Peón G; Abalde MT; Salgado-Boquete L; de la Torre C
    Actas Dermosifiliogr; 2015 Dec; 106(10):e55-61. PubMed ID: 26055975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced degree of irritation during a second cycle of ingenol mebutate gel 0.015% for the treatment of actinic keratosis.
    Jim On SC; Haddican M; Yaroshinsky A; Singer G; Lebwohl M
    Cutis; 2015 Jan; 95(1):47-51. PubMed ID: 25671445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-aging effects of ingenol mebutate for patients with actinic keratosis.
    Kim M; Jung Y; Kim J; Jeong SW; Woo YR; Park HJ
    J Am Acad Dermatol; 2018 Dec; 79(6):1148-1150. PubMed ID: 30420007
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical corticosteroid has no influence on inflammation or efficacy after ingenol mebutate treatment of grade I to III actinic keratoses (AK): A randomized clinical trial.
    Erlendsson AM; Karmisholt KE; Haak CS; Stender IM; Haedersdal M
    J Am Acad Dermatol; 2016 Apr; 74(4):709-15. PubMed ID: 26810403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results.
    Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Larsson T; Swanson N
    J Drugs Dermatol; 2014 Jun; 13(6):741-7. PubMed ID: 24918567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking actinic keratosis of face and scalp treated with 0.015% ingenol mebutate to identify clinical and dermoscopic predictors of treatment response.
    Pampena R; Benati E; Borsari S; Bombonato C; Lombardi M; Raucci M; Mirra M; Lallas A; Apalla Z; Papadimitriou I; Moscarella E; Kyrgidis A; Argenziano G; Pellacani G; Longo C
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1461-1468. PubMed ID: 29356164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas.
    Bucko AD; Jarratt M; Stough DB; Kyhl L; Villumsen J; Hall A
    J Dermatolog Treat; 2018 Feb; 29(1):74-79. PubMed ID: 28524709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Histologic Evaluation of Ingenol Mebutate 0.015% Gel for the Cosmetic Improvement of Photoaged Skin.
    Handler MZ; Bloom BS; Goldberg DJ
    Dermatol Surg; 2018 Jan; 44(1):61-67. PubMed ID: 28858927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
    Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
    J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body.
    Pellacani G; Peris K; Guillen C; Clonier F; Larsson T; Venkata R; Puig S
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2192-8. PubMed ID: 26300464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
    Bettencourt MS
    J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ingenol mebutate gel for actinic keratosis: the link between quality of life, treatment satisfaction, and clinical outcomes.
    Augustin M; Tu JH; Knudsen KM; Erntoft S; Larsson T; Hanke CW
    J Am Acad Dermatol; 2015 May; 72(5):816-21. PubMed ID: 25770879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.